Article
Biomarker-based prediction of response to therapy for colorectal cancer: current perspective.
American journal of clinical pathology - 1 Sept 2010
Ross Jeffrey S, Torres-Mora Jorge, Wagle Nikhil, Jennings Timothy A, Jones David M
Abstract excerpt
The diagnosis and management of colorectal cancer (CRC) has been impacted by the discovery and validation of a wide variety of biomarkers designed to facilitate a personalized approach for the treatment of the disease. Recently, CRC has been reclassified based on molecular analyses of various genes and proteins capable of separating morphologic types of tumors into molecular categories. At the same time, a number...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
